London: The University of Oxford has said that it will reinstate trials with the pharmaceutical company AstraZeneca to develop the Corona Virus vaccine (Vaccine). The trial was stopped after a side effect of the vaccine in a patient in Britain.
The university said in a statement, “There is a fear in such a large trial that some participants will be unwell and safety will be ensured by carefully evaluating each case.” The statement said that around 18,000 people have been given this vaccine worldwide under the test.
Information about the patient’s illness is not disclosed because of maintaining the confidentiality of the person participating in the trial. However, it has been emphasized that he is committed to the safety of the partners by adopting the best standards in his study and will be constantly evaluated deeply regarding safety.
